Navigation Links
Abbott Receives CE Mark for Healon EndoCoat Protective Gel for Cataract Surgery
Date:8/22/2011

SANTA ANA, Calif., Aug. 22, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that it has expanded its Healon® family of ophthalmic viscosurgical devices (OVDs) with the European CE Mark of Healon EndoCoat OVD.

The  clear, viscous, low molecular weight dispersive OVD is intended for use as a surgical aid in cataract extraction, intraocular lens (IOL) implantation, corneal transplantation, and glaucoma filtration surgery.

Healon EndoCoat OVD's formula protects and coats the eye when injected during surgery, and is ideal for intraocular lens (IOL) lubrication and insertion. Additionally, Healon EndoCoat OVD can be used in combination with any other Healon products such as Healon OVD, Healon GV OVD or Healon5 OVD.

Dispersives such as Healon EndoCoat OVD are expected to account for 38 percent of the total OVD market in 2011, according to independent ophthalmic research firm Market Scope.

The Healon EndoCoat OVD delivery system includes a number of features for increased patient safety and ease of handling for the physician, including a smaller, 25-gauge cannula with guard and improved ergonomics of the device for a smooth and consistent delivery.

"Healon EndoCoat [OVD] plays an essential role in my cataract surgeries for overall endothelial cell preservation and patient safety," said Donald Nixon, M.D., surgical director, TriMed Eye Center, Barrie, Ontario, Canada. "Additionally, the mechanical properties of Healon EndoCoat [OVD] provide me with the stability I need throughout the entire cataract procedure for even the most challenging cases."

Healon EndoCoat OVD is available in Europe, Canada and New Zealand and is currently under review by the U.S. Food and Drug Administration. Shipments to other geographies will follow once the company receives necessary regulatory approvals.  Customers who already receive regular shipment
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
2. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
3. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
4. Abbotts ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study
5. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
6. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
7. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
8. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
9. Abbotts XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
10. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 7, 2015   Bionik Laboratories Corp. ... with a core focus in robotic exoskeleton technology ... "Company"), announced today that it has completed an ... consisting of its common stock and warrants for ... a private placement transaction.  This equity financing is ...
(Date:7/7/2015)... Oasmia Pharmaceutical AB, a ... human and veterinary oncology, today announced that it ... the United States , designed to generate ... therapeutic.      (Logo: http://photos.prnewswire.com/prnh/20150420/740096) , ... Paccal Vet-CA1 was previously distributed by ...
(Date:7/7/2015)...  Monopar Therapeutics LLC, an emerging biopharmaceutical company focusing ... and CEO, Chandler D. Robinson MD, MBA, ... Award. The British Council selected one recipient from each ... , and the United States ... who have leveraged their U.K. education in their subsequent ...
Breaking Medicine Technology:Bionik Laboratories Completes US$13.1 Million Private Placement 2Bionik Laboratories Completes US$13.1 Million Private Placement 3Oasmia Pharmaceutical Launches US Brand and Sales Platform 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 3
... pharmaceutical and medical device companies evolve, market research ... refining current ones to support intelligent planning and ... beginning to explore different types of technological advances ... external data collection and internal asset creation. ...
... 2012   CareFusion Corp. (NYSE: CFN ... that its board of directors authorized the repurchase of ... (Logo:  http://photos.prnewswire.com/prnh/20100706/CAREFUSIONLOGO ) "This ... potential and our commitment to increasing shareholder value," said ...
Cached Medicine Technology:Pharmaceutical Industry Leveraging New Tools to Overcome Challenges in Market Research 2CareFusion Announces $500 Million Share Repurchase Program 2CareFusion Announces $500 Million Share Repurchase Program 3
(Date:7/7/2015)... ... July 07, 2015 , ... Difass USA, a modern ... pass those long, stressful days at work is knowing that there is hopefully a ... back and stress free as imagined. Planning for a vacation can be quite stressful, ...
(Date:7/7/2015)... ... , ... The United States Centers for Disease Control and Prevention have awarded ... Multicultural AIDS Coalition $3.78 million for a five-year HIV prevention partnership that will ... transgender women, the groups at highest risk of HIV infection in the US. ...
(Date:7/7/2015)... MD (PRWEB) , ... July 07, 2015 , ... SC&H ... of Service, which aims to give back to the community through company-wide volunteering efforts. ... from SC&H Group dedicate the day to assisting those in need throughout Baltimore and ...
(Date:7/7/2015)... ... July 07, 2015 , ... The Immune Deficiency Foundation ... patient community using its IDF ePHR, an electronic personal health record powered by ... to easily track their health information, including symptoms, diagnoses, medications, infusions and other ...
(Date:7/7/2015)... ... July 07, 2015 , ... FSAstore.com today announced the launch ... holders. HSAstore.com makes it simple to use, spend and manage HSA funds with innovative ... accounts. , According to a report by Devenir , approximately 13.8 million ...
Breaking Medicine News(10 mins):Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:SC&H Group Celebrates 9th Annual Day of Service 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 3
... stem cells, which may provide a treatment for tumors ... pancreatic cancer, according to new research from Memorial Sloan-Kettering ... important since pancreatic cancer has a poor prognosis and ... Investigators led by Joyce Wong, MD, surgical researcher ...
... , NEW YORK (May 6, 2011) -- Among ... meeting are physician-scientists from NewYork-Presbyterian Hospital/Columbia University Medical ... McCormick Place, Chicago. The following are two notable ... A gastroenterologist at NewYork-Presbyterian Hospital/Columbia University Medical Center ...
... gene expression of their lungs similar to that suffered by ... is the conclusion of a new study, led by Catalan ... causing these alterations. "Our objective was to analyse the ... samples of patients with COPD, whether smokers or not, and ...
... up to a year before a patient is diagnosed with ... often mistaken for other diseases. However, with this blood-based test, ... disease or not", says Christer Wingren, associate professor in Immunotechnology ... determine how far the disease has progressed. There are three ...
... post-mortem tissue archive for a study of the human form ... by coroners to participate. The Coroners, Society of England and ... public health" from potential new risks associated with variant Creutzfeldt-Jakob ... of tissue from autopsies. That is the conclusion of a ...
... (HealthDay News) -- Children conceived in winter seem to have ... study suggests. Environmental factors -- including exposure to seasonal ... play a role in the greater risk for autism among ... California, Davis researchers. The investigators analyzed data from 6.6 ...
Cached Medicine News:Health News:Oncolytic viruses effectively target and kill pancreatic cancer stem cells 2Health News:NY Presbyterian/Columbia research presented at Digestive Disease Week meeting 2Health News:Smokers undergo the same changes in gene expression as patients with COPD 2Health News:New test could give SLE patients a more tolerable life 2Health News:Coroners wrong to say no to post-mortem tissue collection, academics argue 2Health News:Winter Conception Tied to Raised Risk for Autism 2
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: